Aclaris Therapeutics (ACRS) to Acquire Vixen Pharma and Rights to Intellectual Property for Potential Treatment for Hair Loss
Tweet Send to a Friend
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
